Markets:

Overview

News

Currencies

International

Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.3704 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Why Skechers Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket ↗

October 26, 2022

Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) rose 53.5% to $0.32 in pre-market trading after gaining 13% on Tuesday.

Via Benzinga

$1.5 Million Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

October 25, 2022

The Dow Jones closed higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Crude Oil Drops Over 2%; Akouos Shares Spike Higher ↗

October 18, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 300 points on Tuesday.

Via Benzinga

Nasdaq Rises Over 100 Points; Goldman Sachs Tops Q3 Views ↗

October 18, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Tuesday.

Via Benzinga

Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants

October 04, 2022

Via ACCESSWIRE

Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday ↗

October 19, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday.

Via Benzinga

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session ↗

October 18, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 18, 2022

During Tuesday's session, 78 companies made new 52-week lows.

Via Benzinga

What's Going On With Cosmos Holdings Stock Falling Sharply? ↗

October 18, 2022

Cosmos Holdings Inc (NASDAQ: COSM) shares are trading lower by 48.67% to $0.07 after the company announced pricing of a $7.5 million upsized public offering at $0.12 per share. What Else?

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 18, 2022

Gainers Akouos (NASDAQ:AKUS) shares moved upwards by 86.2% to $13.05 during Tuesday's pre-market session. The company's market cap stands at $481.5 million.

Via Benzinga

Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering

October 18, 2022

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 13, 2022

Good morning, investor! We're starting off Thursday with a breakdown of the biggest pre-market stock movers this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 12, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 04, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 37.7% to $15.85 during Tuesday's pre-market session. The company's market cap stands at $23.3 million.

Via Benzinga

Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

September 28, 2022

Via ACCESSWIRE

11 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 23, 2022

Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 23, 2022

We're breaking down the biggest pre-market stock movers for Friday morning alongside the news that traders need to know about!

Via InvestorPlace

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 22, 2022

Gainers Genfit (NASDAQ:GNFT) shares increased by 27.4% to $5.12 during Thursday's after-market session. The market value of their outstanding shares is at $255.0 million.

Via Benzinga

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗

September 22, 2022

Gainers

Via Benzinga

Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe

September 22, 2022

Via ACCESSWIRE

Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday ↗

September 21, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 20, 2022

Via Benzinga

Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗

September 20, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 20, 2022

Via Benzinga

Cosmos Health Signs Another Distribution Deal; Expedites Sales Reach Into German And Austrian Markets ($COSM)

September 20, 2022

Via AB Newswire

Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay

September 15, 2022

Via ACCESSWIRE

Cosmos Health Shares Surge 27%, Decoupling From A Decidedly Bearish Market ($COSM)

September 15, 2022

Via AB Newswire

Cosmos Health Posted A 202% Increase In Adjusted EBITDA In 1H/2022; Here’s Why 2H/2022 Is Expected To Be Even Better ($COSM)

September 12, 2022

Via AB Newswire

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.